$2.10
-0.07-3.23%
At Close: -
$2.14
0.041.90%
After Hours: 7:21 AM EDT
15 minutes delayed
Comments
Loading...
Cellectis
CLLSNASDAQ
Cellectis (NASDAQ:CLLS) Stock Quotes, Forecast and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Open | $2.20 |
| Close | $2.10 |
| Volume / Avg. | 15.73K / 56.78K |
| Day Range | 2.08 - 2.20 |
| 52 Wk Range | 0.96 - 3.77 |
| Market Cap | $214.20M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 47 |
| Short Interest | 0.97% |
| Days to Cover | 5.36 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cellectis
Sector
Health Care
Industry
Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologi...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ:CLLS) through any online brokerage.
Who are Cellectis (CLLS) competitors?
Other companies in Cellectis’s space includes: Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Outlook Therapeutics (NASDAQ:OTLK) and Tectonic Therapeutic (NASDAQ:TECX).
What is the target price for Cellectis (CLLS) stock?
There is no analysis for Cellectis.
What is the forecast for Cellectis (CLLS) stock?
Cellectis has a consensus price target of $9.50.
Current stock price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.14 last updated Today at July 17, 2024 at 7:21 AM EDT.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.